BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Bio NC

  Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea

  Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea.

  February 9, 2023

   · 

  7 min read
• Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

  Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding.

  February 9, 2023

   · 

  4 min read
• Genetown

  Aura Biosciences to Participate in Upcoming Investor Conferences - February 9, 2023

  Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences.

  February 9, 2023

   · 

  2 min read
• Genetown

  AVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLDSymposium™ 2023

  AVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLD Symposium ™ 2023.

  February 9, 2023

   · 

  7 min read
• Business

  Baxter Reports Fourth-Quarter and Full-Year 2022 Results

  Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.

  February 9, 2023

   · 

  50 min read
• Fastox awarded Innovation of the Year at the 2023 IMCAS World Congress.

  Swiss biotech Fastox Pharma has been awarded “Innovation of the Year” at the IMCAS conference in Paris from January 26 to 28, 2023.

  February 9, 2023

   · 

  2 min read
• Drug Development

  Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023

  Prolong Pharmaceuticals announced that preliminary data from the recently completed Phase 1 clinical study of PP-007 in acute ischemic stroke patients will be presented in the Late-Breaking Science session during ISC 2023 in Dallas, TX and in the forthcoming PAIRS conference in Dubai.

  February 9, 2023

   · 

  3 min read
• Bio NC

  Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference

  Shattuck Labs, Inc. announced that company management will participate in the SVB Securities Global Biopharma Conference being held virtually February 13-16, 2023.

  February 9, 2023

   · 

  1 min read
• Business

  RadNet, Inc. Announces Date of its Fourth Quarter 2022 Financial Results Conference Call

  RadNet, Inc. announced that it will host a conference call to discuss its fourth quarter 2022 financial results on Tuesday, February 28, 2022 at 7:30 a.m. Pacific Time.

  February 9, 2023

   · 

  1 min read
• Business

  RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors

  RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr W. Ripley (“Rip”) Ballou and Dr Jacques Cholat to its Board of Directors.

  February 9, 2023

   · 

  5 min read